Discover the groundbreaking findings from a study on bispecific T-cell engagers conducted by The Jackson Laboratory. This case study delves into the tools available for assessing cytokine release and tumour growth inhibition. Explore the implications of donor-specific responses and how this knowledge can optimise the development of immunomodulatory therapeutics.

What you will learn:

• The correlation between cytokine release and tumour growth inhibition in the context of bispecifics
• How donor-specific responses impact the efficacy and safety profiles of immunomodulatory therapeutics
• The potential risk of toxicity associated with high cytokine release and its impact on patient outcomes

Don't miss this opportunity to gain valuable insights into the future of bispecifics and the advancement of immuno-oncology therapeutics.

Brought to you by